About   Help   FAQ
Phenotypes associated with this allele
Allele Symbol
Allele Name
Allele ID
Casp8tm1Hed
targeted mutation 1, Stephen M Hedrick
MGI:3696985
Summary 2 genotypes
Jump to Allelic Composition Genetic Background Genotype ID
cn1
Casp8tm1Hed/Casp8tm1Hed
Cd19tm1(cre)Cgn/Cd19+
involves: 129P2/OlaHsd MGI:3697395
cn2
Casp8tm1Hed/Casp8tm1Hed
Tg(KRT14-cre)1Efu/0
Not Specified MGI:4888399


Genotype
MGI:3697395
cn1
Allelic
Composition
Casp8tm1Hed/Casp8tm1Hed
Cd19tm1(cre)Cgn/Cd19+
Genetic
Background
involves: 129P2/OlaHsd
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Casp8tm1Hed mutation (1 available); any Casp8 mutation (42 available)
Cd19tm1(cre)Cgn mutation (11 available); any Cd19 mutation (56 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
immune system
• modest reduction in B1 cells (~10%) in peritoneal cavity is seen
• reduction in percentage of marginal zone B cells is observed
• spleen cell number is increased ~30% compared to wild-type
• in response to LPS and dsRNA, B cells have decreased proliferative response
• cells stimulated through Tlr9 or antigen receptor show similar proliferation and apoptosis to wild-type cells
• mice mount an inferior IgM response to LPS immunization

hematopoietic system
• in response to LPS and dsRNA, B cells have decreased proliferative response
• cells stimulated through Tlr9 or antigen receptor show similar proliferation and apoptosis to wild-type cells
• modest reduction in B1 cells (~10%) in peritoneal cavity is seen
• reduction in percentage of marginal zone B cells is observed
• spleen cell number is increased ~30% compared to wild-type
• mice mount an inferior IgM response to LPS immunization

cellular
• cells treated with LPS or dsRNA show decreased survival (increased apoptosis) compared to controls at 24 hours, with decreased viability starting at 12 hours
• cells stimulated through Tlr9 or antigen receptor show similar proliferation and apoptosis to wild-type cells
• in response to LPS and dsRNA, B cells have decreased proliferative response
• cells stimulated through Tlr9 or antigen receptor show similar proliferation and apoptosis to wild-type cells




Genotype
MGI:4888399
cn2
Allelic
Composition
Casp8tm1Hed/Casp8tm1Hed
Tg(KRT14-cre)1Efu/0
Genetic
Background
Not Specified
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Casp8tm1Hed mutation (1 available); any Casp8 mutation (42 available)
Tg(KRT14-cre)1Efu mutation (0 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
mortality/aging
• about 10% of mutants exhibit a mosaic skin phenotype and survive for months
• about 90% of mutants die by P15, while 10% survive for months

integument
• mutants exhibit an increase in epidermal water loss
• mutants develop atopic dermatitis-like skin disease
• about 90% of mutants exhibit a uniform skin phenotype and die by P15 while mutants that survive longer than P15, exhibit the skin phenotype on the posterior region of the back skin
• 2.5-fold increase in the numbers of blood vessels in the skin as indicated by marker analysis
• 2.5-fold increase in the numbers of blood vessels in the skin as indicated by marker analysis
• cutaneous edema is seen in the ears and feet
• affected skin of mutants surviving longer than P15 shows suprabasal cells with increased intracellular space, indicating development of spongiosis
• hyperproliferation of epithelial stem/progenitor cells in the skin
• the intracellular adhesion apparatus of the epidermis is disrupted, with keratinocytes showing an abnormal punctate localization of E-cadherin (Cdh1) due to increased shedding of E-cadherin
• mutants exhibit epidermal hyperplasia
• topical application of clobetasol, a corticosteroid, substantially reduces the epidermal hyperplasia and abolishes the epidermal gaps

immune system
• mutants exhibit an increase in mast cells with age
• IgE levels are normal in young mutants but adults show a 30-fold increase compared to wild-type mice
• 5-fold increase in serum IgG1 levels in adults
• marker analysis indicates that mutants exhibit a biphastic T-helper cell response, with a TH2 response during the acute phase of dermatitis followed by a TH1 response during the chronic phase of dermatitis
• mutants develop atopic dermatitis-like skin disease
• about 90% of mutants exhibit a uniform skin phenotype and die by P15 while mutants that survive longer than P15, exhibit the skin phenotype on the posterior region of the back skin

homeostasis/metabolism
• cutaneous edema is seen in the ears and feet
• affected skin of mutants surviving longer than P15 shows suprabasal cells with increased intracellular space, indicating development of spongiosis
• mutants exhibit an increase in epidermal water loss

hematopoietic system
• mutants exhibit an increase in mast cells with age
• IgE levels are normal in young mutants but adults show a 30-fold increase compared to wild-type mice
• 5-fold increase in serum IgG1 levels in adults
• marker analysis indicates that mutants exhibit a biphastic T-helper cell response, with a TH2 response during the acute phase of dermatitis followed by a TH1 response during the chronic phase of dermatitis

cardiovascular system
• 2.5-fold increase in the numbers of blood vessels in the skin as indicated by marker analysis

Mouse Models of Human Disease
DO ID OMIM ID(s) Ref(s)
atopic dermatitis DOID:3310 OMIM:603165
OMIM:PS603165
J:167299





Contributing Projects:
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO)
Citing These Resources
Funding Information
Warranty Disclaimer, Privacy Notice, Licensing, & Copyright
Send questions and comments to User Support.
last database update
03/19/2024
MGI 6.23
The Jackson Laboratory